Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1997 1
1999 1
2000 5
2001 2
2002 3
2003 5
2004 9
2005 8
2006 5
2007 8
2008 2
2009 10
2010 12
2011 13
2012 1
2013 1
2014 3
2015 5
2016 1
2017 4
2018 2
2021 1
2022 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

96 results

Results by year

Filters applied: . Clear all
Page 1
Catumaxomab: a bispecific trifunctional antibody.
Sebastian M, Kuemmel A, Schmidt M, Schmittel A. Sebastian M, et al. Among authors: schmittel a. Drugs Today (Barc). 2009 Aug;45(8):589-97. Drugs Today (Barc). 2009. PMID: 19927225 Review.
Second-line therapy for small-cell lung cancer.
Schmittel A. Schmittel A. Expert Rev Anticancer Ther. 2011 Apr;11(4):631-7. doi: 10.1586/era.11.7. Expert Rev Anticancer Ther. 2011. PMID: 21504329 Review.
Recurrence patterns and impact of brain metastases in synchronous single organ oligometastatic lung cancer following local ablative treatment - A multicenter analysis.
Frost N, Roeper J, Velthaus JL, Raspe M, Olive E, Schmittel A, Schmidt B, Wasilewski D, Onken J, Lüders H, Witzenrath M, Senger C, Böhmer D, Loges S, Griesinger F, Modest DP, Grohé C. Frost N, et al. Among authors: schmittel a. Lung Cancer. 2022 Aug;170:165-175. doi: 10.1016/j.lungcan.2022.06.017. Epub 2022 Jul 2. Lung Cancer. 2022. PMID: 35803041
Local ablative treatment for synchronous single organ oligometastatic lung cancer-A propensity score analysis of 180 patients.
Frost N, Tessmer A, Schmittel A, van Laak V, Raspe M, Ruwwe-Glösenkamp C, Brunn M, Senger C, Böhmer D, Ochsenreither S, Temmesfeld-Wollbrück B, Furth C, Schmidt B, Neudecker J, Rückert JC, Suttorp N, Witzenrath M, Grohé C. Frost N, et al. Among authors: schmittel a. Lung Cancer. 2018 Nov;125:164-173. doi: 10.1016/j.lungcan.2018.09.021. Epub 2018 Sep 25. Lung Cancer. 2018. PMID: 30429016
96 results